Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients

Annals of Neurology

Volumn 44, Issue 2, 1998, Pages 216-222

  Ibarreta, Dolores ^a   Urcelay, Elena ^a   Parrilla, Roberto ^a   Ayuso, Matilde S ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACID BASE BALANCE; ALZHEIMER DISEASE; ARTICLE; CELL PH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLAST; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; PROTON TRANSPORT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACID-BASE EQUILIBRIUM; AGED; ALZHEIMER DISEASE; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALMODULIN; CELLS, CULTURED; CYTOSOL; DNA; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN M; ION EXCHANGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; REFERENCE VALUES; SULFONAMIDES;

EID: 0031830218     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440212     Document Type: Article

References (52)

1. Katzman R. Alzheimer's disease. N Engl J Med 1986;314:964-973
2. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885-890
3. Yankner BA, Dawes LR, Fisher S, et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-420
4. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990;250:279-282
5. LaFerla FM, Tinkle BT, Bieberich CJ, et al. The Alzheimer's Ab peptide induces neurodegeneration and apoptoric cell death in ttansgenic mice. Nat Genet 1995;9:21-30
6. Mattson MP, Cheng B, Davis D, et al. Beta-amyloid peptides destabilize calcium homeostasis and render human corticaJ neurons vulnerable to excitotoxicity. J Neurosci 1992; 12:376-389
7. Joseph R, Han E. Amyloid beta-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. Biochem Biophys Res Commun 1992;184:1441-1447
8. Hartmann H, Eckert A, Müller WE. Beta-amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochem Biophys Res Commun 1993;194:1216-1220
9. Eckert A, Hartmann H, Müller WE. Beta-amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett 1993;330:49-52
10. 2+ homeostasis in lymphoblasts from late-onset Alzheimer's disease patients. Alzheimer Dis Assoc Disord 1997;11:220-227
11. Grosmann A, Kukull WA, Jinneman JC, et al. Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with Down's syndrome. Neurobiol Aging 1993; 14:177-185
12. Khachaturian ZS. Calcium regulations: final common pathway for age associated neurodegenerative processes. Neurosci Res Commun 1993;13:s3-s6
13. Siesjo BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1981;1:155-185
14. 2+ and pH. Biochem Biophys Res Commun 1992; 186:782-789
15. Orvos L Jr, Szendrei GI, Lee VM, Mantsch HH. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur J Biochem 1993;211:249-257
16. De Strooper B, Craessaerts K, Dewachter I, et al. Basolateral secretion of amyloid precursor protein in Madin-Datby canine kidney cells is disturbed by alterations of intracellular pH and by introducing a mutation associated with familial Alzheimer's disease. J Biol Chem 1995;270:4058-4065
17. + channels. Science 1994;264:276-279
18. Blass JP. Metabolic alterations common to neural and nonneural cells in Alzheimer's disease. Hippocampus 1993;3:45-53
19. Scott RB. Extraneuronal manifestations of Alzheimer's disease. J Am Geriatr Soc 1993;41:268-276
20. Aman P, Ehlin-Henriksson B, Klein G. Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med 1984;159:208-220
21. Tosato G, Blaese RM, Yarchoan R. Relationship between immunoglobulin production and immortalization by Epstein Barr virus. J Immunol 1985;135:959-964
22. Ounanian A, Guilbert B, Seigneurin J-M. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls. Mech Ageing Dev 1992;63:105-116
23. Gambier JC, Ransom JT. Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu Rev Immunol 1987;5: 175-199
24. 2+ -ATPase in vascular smooth muscle cells. J Clin Invest 1995;95:1480-1489
25. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-944
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
27. Myers RM, Lumelsky N, Lerman LS, Maniatis T. Detection of single base substitutions in total genomic DNA. Nature 1985; 313:495-498
28. Kim TW, Tanzi RE. Presenilins and Alzheimer's disease. Curr Opin Neurobiol 1997;7:683-688
29. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159
30. Ibarreta D, Gómez-Isla T, Portera-Sánchez A, et al. Apolipoprotein E phenotype in patients of Alzheimer or Parkinson disease from the Spanish population. J Neurol Sci 1995;134: 146-149
31. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scan J Clin Lab Invest 1968;21(Suppl 97):77-89
32. Walls EV, Crawford DH. Generation of human B lymphoblastoid cell lines using Epstein-Barr virus. In: Klaus GGB, ed. Lymphocytes, a practical approach. Oxford: IRL Press, 1987: 149-162
33. Thomas JA, Buuchsbaum RN, Zinniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979;18: 2210-2218
34. + antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest 1994;24:529-539
35. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450
36. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 1989;988:73-97
37. Hidaka H, Sasaki Y, Tanaka T, et al. N-(6-Aminohexyl) 1-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci 1981;78:4354-4357
38. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesul-fonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984;23:5036-5041
39. 2 + -ATPase in vascular smooth muscle cells. J Clin Invest 1995;95:1480-1489
40. + exchanger in renal microvillus membrane vesicles. Nature 1982;299:161-163
41. Lesburg C, Li S, Cragoe EJ, Deth RC. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta. J Pharmacol Exp Ther 1990;253:530-536
42. + exchanger. J Membr Biol 1986;90:1-12
43. Moolenaar WH, Tertoolen LG, de Laat SW. Phorbol ester and diacylglycerol mimic growth factors in raising cytoplasmic pH. Nature 1984;312:371-374
44. + antiporter in Chinese hamster embryo fibroblasts. J Cell Physiol 1987;132:311-317
45. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J Biol Chem 1994;269:13703-13709
46. 2+ regulation-defective. J Biol Chem 1994;269:13710-13715
47. 2+/ calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1. J Virol 1994;68:1697-1705
48. Page DM, Gold M, Fahey KA, et al. Mutational analysis of antigen receptor regulation of B lymphocyte growth evidence for involvement of the phosphoinositide signaling pathway. J Biol Chem 1991;266:5563-5574
49. 2+ and pH. Biochem Biophys Res Commun 1992;186:782-789
50. + antiport. J Biol Chem 1995; 270:3203-3211
51. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995;10:19-45
52. LaFerla FM, Tonkle BT, Bieberich CJ, et al. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 1995;9:21-30